Y0000714
Ritonavir
European Pharmacopoeia (EP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 155213-67-5
Synonym(S): 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 80 MG | Y0000714-80-MG | In Stock | ₹ 15,966.88 |
Y0000714 - 80 MG
In Stock
Quantity
1
Base Price: ₹ 15,966.88
GST (18%): ₹ 2,874.038
Total Price: ₹ 18,840.918
biological source
synthetic
grade
pharmaceutical primary standard
Agency
EP
API family
ritonavir
packaging
pkg of 80 mg
manufacturer/tradename
EDQM
storage condition
protect from light
solubility
ethanol: solublemethanol: soluble
application(s)
pharmaceutical (small molecule)
format
neat
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
eMolecules RITONAVIR | 155213-67-5 | MFCD00927142 | 5g | -- | ₹ 19,912.86 | ||
Ritonavir Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,035.30 | ||
Selleck Chemical LLC Ritonavir 10mg 155213-67-5 ABT-538, A 84538 | -- | ₹ 15,699.60 | ||
Sigma Aldrich Fine Chemicals Biosciences Ritonavir European Pharmacopoeia (EP) Reference Standard | 155213-67-5 | | -- | ₹ 24,531.07 | ||
Ritonavir | -- | ₹ 40,756.13 | ||
Ritonavir | -- | ₹ 21,401.03 | ||
Ritonavir for peak identification | -- | ₹ 15,966.88 | ||
Ritonavir | -- | ₹ 1,513.00 - ₹ 1,34,657.00 | ||
155213-67-5 | 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- | -- | ₹ 1,246.00 - ₹ 61,410.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.[1]
- Application: This European Pharmacopoeia reference standard is intended for use only as specifically prescribed in the European Pharmacopoeia.
- Packaging: The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable